A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulins in Insulin Naïve Patients Initiating Insulin

NCT02967224 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

705

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: insulin glargine (U300)
DRUG: insulin glargine (U100)
DRUG: NPH insulin
DRUG: insulin detemir
DRUG: insulin degludec

Sponsor

Sanofi